Principal Financial Group Inc. trimmed its position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Free Report) by 0.9% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 3,208,351 shares of the company’s stock after selling 28,512 shares during the quarter. Principal Financial Group Inc.’s holdings in Aveanna Healthcare were worth $3,818,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of the company. Zurcher Kantonalbank Zurich Cantonalbank bought a new stake in Aveanna Healthcare during the 2nd quarter worth approximately $25,000. Lazard Asset Management LLC acquired a new stake in shares of Aveanna Healthcare in the second quarter valued at $26,000. Citigroup Inc. raised its holdings in shares of Aveanna Healthcare by 6,083.2% in the second quarter. Citigroup Inc. now owns 15,458 shares of the company’s stock valued at $26,000 after buying an additional 15,208 shares during the last quarter. Deutsche Bank AG lifted its position in Aveanna Healthcare by 67.8% during the 1st quarter. Deutsche Bank AG now owns 26,882 shares of the company’s stock worth $28,000 after buying an additional 10,863 shares in the last quarter. Finally, Creative Planning bought a new stake in Aveanna Healthcare during the 4th quarter worth about $31,000. Institutional investors and hedge funds own 88.58% of the company’s stock.
Aveanna Healthcare Price Performance
Shares of NASDAQ:AVAH opened at $2.41 on Thursday. The company has a 50 day moving average of $2.52 and a 200-day moving average of $1.89. Aveanna Healthcare Holdings Inc. has a one year low of $0.85 and a one year high of $3.00. The stock has a market cap of $459.66 million, a price-to-earnings ratio of -1.30 and a beta of 2.05.
Wall Street Analysts Forecast Growth
Several analysts have recently commented on AVAH shares. JPMorgan Chase & Co. cut shares of Aveanna Healthcare from a “neutral” rating to an “underweight” rating in a research note on Wednesday, December 13th. UBS Group began coverage on Aveanna Healthcare in a research report on Thursday, November 30th. They issued a “sell” rating and a $1.50 price objective on the stock. Three equities research analysts have rated the stock with a sell rating and two have given a hold rating to the company’s stock. Based on data from MarketBeat, Aveanna Healthcare currently has an average rating of “Reduce” and an average target price of $1.78.
Aveanna Healthcare Company Profile
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.
- Five stocks we like better than Aveanna Healthcare
- Retail Stocks Investing, Explained
- What are specialty REITs? How to invest in them
- How to Invest in Renewable Energy
- Miso Robotics stock: Is an IPO coming soon?
- How to invest in blue chip stocks
- Insiders are selling these hot stocks on track for higher prices
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.